Related references
Note: Only part of the references are listed.The Other Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry)
Mark P. Thomas et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
The Rationale of the Myo-Inositol and D-Chiro-Inositol Combined Treatment for Polycystic Ovary Syndrome
Simona Dinicola et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Harpal S. Randeva et al.
ENDOCRINE REVIEWS (2012)
The effects of old, new and emerging medicines on metabolic aberrations in PCOS
Alexandra Bargiota et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2012)
The Adapter Protein APPL1 Links FSH Receptor to Inositol 1,4,5-Trisphosphate Production and Is Implicated in Intracellular Ca2+ Mobilization
Richard M. Thomas et al.
ENDOCRINOLOGY (2011)
Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome
Asa Nybacka et al.
FERTILITY AND STERILITY (2011)
Insulin and hyperandrogenism in women with polycystic ovary syndrome
Catherine G. Baptiste et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
Stefano Palomba et al.
ENDOCRINE REVIEWS (2009)
Contribution of myo-inositol to reproduction
E. Papaleo et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2009)
Evidence of proatherogenic inflammation in polycystic ovary syndrome
Frank Gonzalez et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
Evanthia Diamanti-Kandarakis
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Pathophysiology and types of dyslipidemia in PCOS
Evanthia Diamanti-Kandarakis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Phosphoinositides in cell regulation and membrane dynamics
Gilbert Di Paolo et al.
NATURE (2006)
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
AJ Cussons et al.
ATHEROSCLEROSIS (2006)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
The prevalence and features of the polycystic ovary syndrome in an unselected population
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
JM Lord et al.
BRITISH MEDICAL JOURNAL (2003)
Insulin sensitizers for polycystic ovary syndrome
JP Baillargeon et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2003)
Obesity and the polycystic ovary syndrome
A Gambineri et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Polycystic ovary syndrome is associated with endothelial dysfunction
G Paradisi et al.
CIRCULATION (2001)